Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have received a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $45.14.
TRUP has been the subject of several analyst reports. Piper Sandler decreased their price objective on Trupanion from $32.00 to $28.00 and set a “neutral” rating for the company in a report on Friday, November 3rd. StockNews.com raised Trupanion from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th.
Trupanion Stock Performance
Insider Buying and Selling
In other Trupanion news, Director Michael Doak sold 8,688 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $29.99, for a total transaction of $260,553.12. Following the completion of the sale, the director now directly owns 5,866 shares in the company, valued at approximately $175,921.34. The transaction was disclosed in a document filed with the SEC, which is available through this link. 5.81% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Trupanion
Large investors have recently bought and sold shares of the company. Cerity Partners LLC purchased a new stake in Trupanion during the 1st quarter worth approximately $970,000. Belpointe Asset Management LLC grew its position in shares of Trupanion by 2,500.0% in the first quarter. Belpointe Asset Management LLC now owns 832 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 800 shares in the last quarter. Captrust Financial Advisors grew its position in shares of Trupanion by 162.6% in the first quarter. Captrust Financial Advisors now owns 893 shares of the financial services provider’s stock valued at $80,000 after purchasing an additional 553 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of Trupanion by 128.4% in the first quarter. Tower Research Capital LLC TRC now owns 1,039 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 584 shares in the last quarter. Finally, BluePath Capital Management LLC purchased a new stake in shares of Trupanion in the third quarter valued at approximately $31,000.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
- Five stocks we like better than Trupanion
- How Technical Indicators Can Help You Find Oversold Stocks
- Advanced Auto Parts may be worth more in pieces than the whole
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- The Trade Desk train returns to the station
- What Are Defense Contractor Stocks? How to Invest in Defense
- 2 low priced AdTech stocks to ride the advertising rebound
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.